APO Research
Talk to an analyst

APO RESEARCH · REPORT

Newcastle Disease Vaccine

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Selected research

Market Structure

Global Newcastle Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

25 December 2025199 pages

Choose your research edition.

Industry ResearchNewcastle Disease Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Newcastle Disease Vaccine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Newcastle Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Newcastle Disease Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Newcastle Disease Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.

Read the full market overview

This report provides an overview of the global Newcastle Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Newcastle Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Newcastle Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Newcastle Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Newcastle Disease Vaccine Segment by Company

Merial

CEVA

QYH Biotech

Ringpu Biology

Yebio

Harbin Veterinary Research Institute

Merck Animal Health

DHN

Zoetis

ChengDu Tecbond

Elanco (Lohmann)

FATRO

CAVAC

Vaksindo

Newcastle Disease Vaccine Segment by Type

Live Vaccines

Killed Vaccines

Newcastle Disease Vaccine Segment by Application

Chicken

Duck & Goose

Other

Newcastle Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Newcastle Disease Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Newcastle Disease Vaccine Industry Trends Table 2. Newcastle Disease Vaccine Industry Drivers Table 3. Newcastle Disease Vaccine Industry Opportunities and Challenges Table 4. Newcastle Disease Vaccine Industry Restraints Table 5. Global Newcastle Disease Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Newcastle Disease Vaccine Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers Table 9. Global Newcastle Disease Vaccine Average Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 10. Global Newcastle Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Newcastle Disease Vaccine Manufacturers, Product Type & Application Table 13. Global Newcastle Disease Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Vaccines Table 17. Major Manufacturers of Killed Vaccines Table 18. Global Newcastle Disease Vaccine Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 20. Global Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 21. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Newcastle Disease Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Newcastle Disease Vaccine Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 24. Global Newcastle Disease Vaccine Revenue by Type (2021-2026) & (M Doses) Table 25. Global Newcastle Disease Vaccine Revenue by Type (2027-2032) & (M Doses) Table 26. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Newcastle Disease Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Chicken Table 29. Major Manufacturers of Duck & Goose Table 30. Major Manufacturers of Other Table 31. Global Newcastle Disease Vaccine Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 32. Global Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 33. Global Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 34. Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Newcastle Disease Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Newcastle Disease Vaccine Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 37. Global Newcastle Disease Vaccine Revenue by Application (2021-2026) & (M Doses) Table 38. Global Newcastle Disease Vaccine Revenue by Application (2027-2032) & (M Doses) Table 39. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Newcastle Disease Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Newcastle Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 42. Global Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses) Table 43. Global Newcastle Disease Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Newcastle Disease Vaccine Sales Forecasted by Region (2027-2032) & (M Doses) Table 45. Global Newcastle Disease Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 47. North America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 48. North America Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 49. Europe Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 50. Europe Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 51. Europe Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 52. Asia Pacific Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 53. Asia Pacific Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 54. Asia Pacific Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 55. South America, Middle East and Africa Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. South America, Middle East and Africa Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 57. South America, Middle East and Africa Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 58. Global Newcastle Disease Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Newcastle Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Newcastle Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Newcastle Disease Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Newcastle Disease Vaccine Revenue Market Share by Region (2027-2032) Table 63. Merial Company Information Table 64. Merial Business Overview Table 65. Merial Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merial Newcastle Disease Vaccine Product Portfolio Table 67. Merial Recent Development Table 68. CEVA Company Information Table 69. CEVA Business Overview Table 70. CEVA Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. CEVA Newcastle Disease Vaccine Product Portfolio Table 72. CEVA Recent Development Table 73. QYH Biotech Company Information Table 74. QYH Biotech Business Overview Table 75. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. QYH Biotech Newcastle Disease Vaccine Product Portfolio Table 77. QYH Biotech Recent Development Table 78. Ringpu Biology Company Information Table 79. Ringpu Biology Business Overview Table 80. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Ringpu Biology Newcastle Disease Vaccine Product Portfolio Table 82. Ringpu Biology Recent Development Table 83. Yebio Company Information Table 84. Yebio Business Overview Table 85. Yebio Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Yebio Newcastle Disease Vaccine Product Portfolio Table 87. Yebio Recent Development Table 88. Harbin Veterinary Research Institute Company Information Table 89. Harbin Veterinary Research Institute Business Overview Table 90. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio Table 92. Harbin Veterinary Research Institute Recent Development Table 93. Merck Animal Health Company Information Table 94. Merck Animal Health Business Overview Table 95. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Merck Animal Health Newcastle Disease Vaccine Product Portfolio Table 97. Merck Animal Health Recent Development Table 98. DHN Company Information Table 99. DHN Business Overview Table 100. DHN Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. DHN Newcastle Disease Vaccine Product Portfolio Table 102. DHN Recent Development Table 103. Zoetis Company Information Table 104. Zoetis Business Overview Table 105. Zoetis Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Zoetis Newcastle Disease Vaccine Product Portfolio Table 107. Zoetis Recent Development Table 108. ChengDu Tecbond Company Information Table 109. ChengDu Tecbond Business Overview Table 110. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio Table 112. ChengDu Tecbond Recent Development Table 113. Elanco (Lohmann) Company Information Table 114. Elanco (Lohmann) Business Overview Table 115. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio Table 117. Elanco (Lohmann) Recent Development Table 118. FATRO Company Information Table 119. FATRO Business Overview Table 120. FATRO Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. FATRO Newcastle Disease Vaccine Product Portfolio Table 122. FATRO Recent Development Table 123. CAVAC Company Information Table 124. CAVAC Business Overview Table 125. CAVAC Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. CAVAC Newcastle Disease Vaccine Product Portfolio Table 127. CAVAC Recent Development Table 128. Vaksindo Company Information Table 129. Vaksindo Business Overview Table 130. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Vaksindo Newcastle Disease Vaccine Product Portfolio Table 132. Vaksindo Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Newcastle Disease Vaccine Distributors List Table 136. Newcastle Disease Vaccine Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Newcastle Disease Vaccine Product Image Figure 2. Global Newcastle Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Newcastle Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Newcastle Disease Vaccine Sales (2021-2032) & (M Doses) Figure 5. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Vaccines Image Figure 9. Killed Vaccines Image Figure 10. Global Newcastle Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 11. Global Newcastle Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Newcastle Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Newcastle Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Chicken Image Figure 17. Duck & Goose Image Figure 18. Other Image Figure 19. Global Newcastle Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 20. Global Newcastle Disease Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Newcastle Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 23. Global Newcastle Disease Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 26. North America Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Canada Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Mexico Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 31. Europe Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. France Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. U.K. Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Italy Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Netherlands Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 38. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. Japan Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. South Korea Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. Southeast Asia Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. India Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. Australia Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 46. South America, Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. South Africa Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Saudi Arabia Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Turkey Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. Argentina Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. UAE Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Egypt Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Chile Newcastle Disease Vaccine Sales and Growth Rate (2021-2032) & (M Doses) Figure 55. Global Newcastle Disease Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Newcastle Disease Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Newcastle Disease Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Newcastle Disease Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Newcastle Disease Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Chicken
  • Duck & Goose
  • Other
Companies covered
  • Merial
  • CEVA
  • QYH Biotech
  • Ringpu Biology
  • Yebio
  • Harbin Veterinary Research Institute
  • Merck Animal Health
  • DHN
  • Zoetis
  • ChengDu Tecbond
  • Elanco (Lohmann)
  • FATRO
  • CAVAC
  • Vaksindo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Newcastle Disease Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Newcastle Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Newcastle Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Newcastle Disease Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Newcastle Disease Vaccine Market Dynamics
  1. 2.1 Newcastle Disease Vaccine Industry Trends
  2. 2.2 Newcastle Disease Vaccine Industry Drivers
  3. 2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Newcastle Disease Vaccine Industry Restraints
3 Newcastle Disease Vaccine Market by Manufacturers
  1. 3.1 Global Newcastle Disease Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Newcastle Disease Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Newcastle Disease Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Newcastle Disease Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Newcastle Disease Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Newcastle Disease Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Newcastle Disease Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Newcastle Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Newcastle Disease Vaccine Market by Type
  1. 4.1 Newcastle Disease Vaccine Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global Newcastle Disease Vaccine Sales by Type
  5. 4.2.1 Global Newcastle Disease Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Newcastle Disease Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Newcastle Disease Vaccine Revenue by Type
  9. 4.3.1 Global Newcastle Disease Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Newcastle Disease Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2032)
5 Newcastle Disease Vaccine Market by Application
  1. 5.1 Newcastle Disease Vaccine Application Introduction
  2. 5.1.1 Chicken
  3. 5.1.2 Duck & Goose
  4. 5.1.3 Other
  5. 5.2 Global Newcastle Disease Vaccine Sales by Application
  6. 5.2.1 Global Newcastle Disease Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Newcastle Disease Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Newcastle Disease Vaccine Revenue by Application
  10. 5.3.1 Global Newcastle Disease Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Newcastle Disease Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032)
6 Global Newcastle Disease Vaccine Sales by Region
  1. 6.1 Global Newcastle Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Newcastle Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Newcastle Disease Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Newcastle Disease Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Newcastle Disease Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Newcastle Disease Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Newcastle Disease Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Newcastle Disease Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Newcastle Disease Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Newcastle Disease Vaccine Revenue by Region
  1. 7.1 Global Newcastle Disease Vaccine Revenue by Region
  2. 7.1.1 Global Newcastle Disease Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Newcastle Disease Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Newcastle Disease Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Newcastle Disease Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Newcastle Disease Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Newcastle Disease Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Newcastle Disease Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Newcastle Disease Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Newcastle Disease Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merial
  2. 8.1.1 Merial Company Information
  3. 8.1.2 Merial Business Overview
  4. 8.1.3 Merial Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merial Newcastle Disease Vaccine Product Portfolio
  6. 8.1.5 Merial Recent Developments
  7. 8.2 CEVA
  8. 8.2.1 CEVA Company Information
  9. 8.2.2 CEVA Business Overview
  10. 8.2.3 CEVA Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
  12. 8.2.5 CEVA Recent Developments
  13. 8.3 QYH Biotech
  14. 8.3.1 QYH Biotech Company Information
  15. 8.3.2 QYH Biotech Business Overview
  16. 8.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
  18. 8.3.5 QYH Biotech Recent Developments
  19. 8.4 Ringpu Biology
  20. 8.4.1 Ringpu Biology Company Information
  21. 8.4.2 Ringpu Biology Business Overview
  22. 8.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
  24. 8.4.5 Ringpu Biology Recent Developments
  25. 8.5 Yebio
  26. 8.5.1 Yebio Company Information
  27. 8.5.2 Yebio Business Overview
  28. 8.5.3 Yebio Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
  30. 8.5.5 Yebio Recent Developments
  31. 8.6 Harbin Veterinary Research Institute
  32. 8.6.1 Harbin Veterinary Research Institute Company Information
  33. 8.6.2 Harbin Veterinary Research Institute Business Overview
  34. 8.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
  36. 8.6.5 Harbin Veterinary Research Institute Recent Developments
  37. 8.7 Merck Animal Health
  38. 8.7.1 Merck Animal Health Company Information
  39. 8.7.2 Merck Animal Health Business Overview
  40. 8.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
  42. 8.7.5 Merck Animal Health Recent Developments
  43. 8.8 DHN
  44. 8.8.1 DHN Company Information
  45. 8.8.2 DHN Business Overview
  46. 8.8.3 DHN Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DHN Newcastle Disease Vaccine Product Portfolio
  48. 8.8.5 DHN Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 ChengDu Tecbond
  56. 8.10.1 ChengDu Tecbond Company Information
  57. 8.10.2 ChengDu Tecbond Business Overview
  58. 8.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
  60. 8.10.5 ChengDu Tecbond Recent Developments
  61. 8.11 Elanco (Lohmann)
  62. 8.11.1 Elanco (Lohmann) Company Information
  63. 8.11.2 Elanco (Lohmann) Business Overview
  64. 8.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
  66. 8.11.5 Elanco (Lohmann) Recent Developments
  67. 8.12 FATRO
  68. 8.12.1 FATRO Company Information
  69. 8.12.2 FATRO Business Overview
  70. 8.12.3 FATRO Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
  72. 8.12.5 FATRO Recent Developments
  73. 8.13 CAVAC
  74. 8.13.1 CAVAC Company Information
  75. 8.13.2 CAVAC Business Overview
  76. 8.13.3 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
  78. 8.13.5 CAVAC Recent Developments
  79. 8.14 Vaksindo
  80. 8.14.1 Vaksindo Company Information
  81. 8.14.2 Vaksindo Business Overview
  82. 8.14.3 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
  84. 8.14.5 Vaksindo Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Newcastle Disease Vaccine Value Chain Analysis
  2. 9.1.1 Newcastle Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Newcastle Disease Vaccine Production Mode & Process
  6. 9.2 Newcastle Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Newcastle Disease Vaccine Distributors
  9. 9.2.3 Newcastle Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst